• 검색 결과가 없습니다.

Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?

N/A
N/A
Protected

Academic year: 2021

Share "Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?"

Copied!
4
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Fig. 1. Distribution of the patients in the iMODEL (model A, in blue) and the Arbeitsgemeinschaft Gynäkologische  Onkologie (AGO) model (in light green), data were from the international collaborative pooled analyses (with  thanks to Drs

참조

관련 문서

The effect of group exercise on physical functioning and falls in frail older people living in retirement villages: a randomized, controlled trial... Wyman JF, Croghan

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)..

Results: 44 of 1048 patients with gastric cancer(4.1%) had synchronous and metachronous cancers. The average time interval between gastric cancer and secondary primary cancer

Postoperative adhesion formation and reproductive outcome using interceed ® after ovarian surgery: a randomized trial in the rabbit model.. Adhesion reformation

A Systematics and Ecological Notes on Marine Polychaetes (Annelida, Polychaeta) from Korea, with the Secondary Production of Hediste japonica Population in Suncheon

Sedation, analgesia, and cardiorespiratory function in colonoscopy using midazolam combined with fentanyl or propofol.. A randomized, double-blind, phase 3 study

Second, the analysis of differences by affiliation showed that the controlled coaching actions were perceived higher in order of the general, secondary, and

Although SAMMPRIS with the Wingspan stent failed to show a benefit for intracranial stenting over intensive medical management in the secondary prevention of stroke